Xiaosong Chen
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Cancer Research 104
- Breast Cancer Treatment Studies 97
- Cancer, Lipids, and Metabolism 4
- Oncology 30
- HER2/EGFR in Cancer Research 15
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Kunwei Shen (132 shared papers)Ou Huang (59 shared papers)Jiayi Wu (58 shared papers)Xiaochun Fei (36 shared papers)Shuning Ding (9 shared papers)Qing Qu (5 shared papers)Weiguo Chen (53 shared papers)Yafen Li (50 shared papers)
- Journals
- Frontiers in Oncology (15 papers)BMC Cancer (6 papers)Breast Cancer Research and Treatment (6 papers)Scientific Reports (6 papers)Journal of Cancer (6 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiaosong Chen
170 papers receiving 4.3k citations
Xiaosong Chen's Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 1.4k
- Oncology 895
- Hepatology 224
- Radiology, Nuclear Medicine and Imaging 465
- Pathology and Forensic Medicine 279
Countries citing papers authored by Xiaosong Chen
This map shows the geographic impact of Xiaosong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaosong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaosong Chen more than expected).
Fields of papers citing papers by Xiaosong Chen
This network shows the impact of papers produced by Xiaosong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaosong Chen. The network helps show where Xiaosong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaosong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 217 | |
| 2 | 2015 | 205 | |
| 3 | 2014 | 193 | |
| 4 | 2020 | 192 | |
| 5 | 2014 | 178 | |
| 6 | Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials Hit paper breakdown → | 2023 | 134 |
| 7 | 2010 | 125 | |
| 8 | 2017 | 111 | |
| 9 | 2013 | 97 | |
| 10 | 2012 | 95 | |
| 11 | 2015 | 78 | |
| 12 | 2012 | 76 | |
| 13 | 2021 | 76 | |
| 14 | 2021 | 74 | |
| 15 | 2014 | 73 | |
| 16 | 2013 | 61 | |
| 17 | 2016 | 56 | |
| 18 | 2013 | 55 | |
| 19 | 2016 | 54 | |
| 20 | 2023 | 54 |
About Xiaosong Chen
Xiaosong Chen is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Hepatology and Radiology, Nuclear Medicine and Imaging, having authored 177 papers that have together received 4.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (97 papers), HER2/EGFR in Cancer Research (15 papers), Breast Lesions and Carcinomas (11 papers), Organ Transplantation Techniques and Outcomes (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), MRI in cancer diagnosis (4 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (895 citations), Hepatology (224 citations), Radiology, Nuclear Medicine and Imaging (465 citations) and Pathology and Forensic Medicine (279 citations). Xiaosong Chen has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Kunwei Shen, Ou Huang, Jiayi Wu, Xiaochun Fei, Shuning Ding, Qing Qu, Weiguo Chen, Yafen Li, Yan Mao and Jianrong He. Their work appears in journals such as Frontiers in Oncology, BMC Cancer, Breast Cancer Research and Treatment, Scientific Reports and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.